Is Embecta Corp. (EMBC) a Buy, Sell, or Hold?
NASDAQ : EMBC
Embecta Corp.
$4.42 USD
$0.92 (26.29%)
- Volume
- 5.57M
- Average Volume
- 2.47M
- Market Capitalization
- $262.23M
- P/E Ratio
- 2.97
- Dividend Yield
- 10.41%
- Price Target
- $5.00
- Year High
- $15.55
- Year Low
- $2.77
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.31
- Current Ratio
- $1.68
Company Overview
NASDAQ
Devdatt Kurdikar
Drug Manufacturers - Specialty & Generic
Healthcare
EMBC
1850
US
USD
Liquidity Metrics
-2.43
1.68
1.17
0.51
0.31
Sales & Valuation
$1.08B
0.26
-0.42
1.59
2.82
Profitability
$1.62
$95.4M
8.59%
12.27%
-13.98%
6.92%
P/E Metrics
2.97
0.60
0.60
Analyst Price Target & Rating
$5.00
$5.00
$5.00
3/5
4 Analysts
-11.60%
Financial Health Scores
1.35
6/9
$285.3M
$1.27B
$1.88B
$244.6M
Key Metrics (TTM)
$1.53B
1.51
5.89
1.68
-13.98%
17.92%
33.91%
62.77%
173 days
Company Executives
| Name | Title |
|---|---|
| Devdatt Kurdikar | President, CEO & Chairman |
| Jacob Elguicze | Senior Vice President & Chief Financial Officer |
| Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain |
| Jean Casner | Senior Vice President & Chief Human Resources Officer |
| Anthony Roth | Vice President, Chief Accounting Officer & Corporate Controller |
| Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary |
| Pravesh Khandelwal | Vice President & Head of Investor Relations |
| Slobodan Radumilo | Senior Vice President & President of International |
| Tom Blount | Senior Vice President & President of North America |
| Ginny Blocki | Senior Vice President of Strategy |
Poll Results
No votes yet today — be the first to share your view!
About Embecta Corp. (NASDAQ:EMBC) Stock
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022. ...
2026-08-08 06:17:00
New York, New York--(Newsfile Corp. - August 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 17, 2026 lead plaintiff deadline. SO WHAT: If you purchased Embecta common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Embecta Corp. (EMBC) Q3 2026 Earnings Call Transcript
2026-08-07 18:44:05
Embecta Corp. (EMBC) Q3 2026 Earnings Call Transcript
2026-08-07 17:17:00
NEW YORK, Aug. 7, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 17, 2026 lead plaintiff deadline. So what: If you purchased Embecta common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
2026-08-07 14:58:00
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August 17, 2026 lead plaintiff deadline.
2026-08-07 14:45:00
New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC) on behalf of investors that purchased or otherwise acquired Embecta securities between November 25, 2025 and May 4, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Embecta and have suffered losses, you may CLICK HERE to contact us.
2026-08-07 12:00:00
New York, New York--(Newsfile Corp. - August 7, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
2026-08-07 12:00:00
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Embecta securities between November 25, 2025 and May 4, 2026, both dates inclusive (the “Class Period”).
2026-08-07 10:12:00
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Embecta Corp. (NASDAQ: EMBC).
Frequently Asked Questions
-
What is the current Embecta Corp. (EMBC) stock price?
-
Embecta Corp.(NASDAQ:EMBC) stock price is $4.42 in the last trading session. During the trading session, EMBC stock reached the peak price of $15.55 while $2.77 was the lowest point it dropped to. The percentage change in EMBC stock occurred in the recent session was 26.29% while the dollar amount for the price change in EMBC stock was $0.92.
-
EMBC's industry and sector of operation?
-
The NASDAQ listed EMBC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of EMBC?
-
Devdatt Kurdikar | President, CEO & Chairman
Jacob Elguicze | Senior Vice President & Chief Financial Officer
Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain
Jean Casner | Senior Vice President & Chief Human Resources Officer
Anthony Roth | Vice President, Chief Accounting Officer & Corporate Controller -
How many employees does EMBC have?
-
Number of EMBC employees currently stands at 1850. EMBC operates from 300 Kimball Drive, Parsippany, NJ 07054, US.
-
Link for EMBC official website?
-
Official Website of EMBC is: https://www.embecta.com
-
How do I contact EMBC?
-
EMBC could be contacted at phone #201 847 6880 and can also be accessed through its website. EMBC operates from 300 Kimball Drive, Parsippany, NJ 07054, US.
-
How many shares of EMBC are traded daily?
-
The average number of EMBC shares traded daily for last 3 months was 2.47M.
-
What is the market cap of EMBC currently?
-
The market value of EMBC currently stands at $262.23M with its latest stock price at $4.42